Just some real quick notes on Strategy ahead and positions Im currently doing the due diligence on our next position which I am quite excited about. A few teasers are in order. The CEO and Founder has an 85% stake after the IPO as he likes...
SAMAW at 2.40 (now CLRVW) We had an initial average entry at 1.25, I then said to add at 50-70 cents a few times. Our average should be around 95 cents even $1 if you followed advisories Now this vote will be on 12/17 to merge officially...
Obviously the market has been strong and small caps are finally strongly in favor, which helps with our positions. There are tons of names moving up every day in the market and I see them all, but we cant have 15-20 names here in the...
Updates on TPS positions Interesting to see SOLO at $13 a share today, some 19 months after I wrote it up in early 2019 for TPS members at $1.25 per share. We sold out at a spike to 5 in April, so we didnt complain as...
After a chaotic month of October which I expected, we are now ready for some updates and game planning for TPS portfolio and a likely 1-2 new additions soon as well Make sure you follow news feeds on Yahoo Finance for all symbols so you can...
Our last update was September 17th, so now is a good time as we enter the 4th quarter for some quick notes LTRN- $19.90 area Our latest research at 17.50 was as high as 21.25 recently, and they continue to progress with more news out today on...
Time for some position updates. I will likely issue a new report within next 2-4 weeks to add to our portfolio. ATOM, TFFP, PRVB, INMB all looking strong. Under water in CRBP, TBIO, and SAMAW for now...
CRBP 2.50 Average entry $5 Analyst high target $40 77% drop on Tuesday as results of the Phase 3 trial were not much better than placebo group. This was unexpected by those running the trials and management. It is thought that perhaps the Immunosuppressive drugs that 84% of...
INMB at 9.40 1 day after report, high of 10.60 on 8/20 post report and now 9.20 low today I have a few more items to help understand what they are doing with their TNF Inhibitor science which targets Inflammation and Cytokine storm issues that cause...
TFFP announced their quarterly update yesterday and the stock rallied as high as $14 post close from $10.28 52 week highs afterwards. They announced a worldwide licensing agreement for Niclosamide with Union Therapeutics. This is transformational and has 210 million in milestone payments, royalties, and...
indian xxnx horny desi indian cheating slime wife show boobs in webcam.
